Veterinary Medicines

Recudon 5 mg/ml + 0.25 mg/ml solution for injection for horses and dogs

Authorised
  • Levomethadone
Download as PDF

Product identification

Medicine name:
Recudon 5 mg/ml + 0.25 mg/ml solution for injection for horses and dogs
Recudon 5 mg/ml + 0,25 mg/ml raztopina za injiciranje za konje in pse
Active substance:
  • Levomethadone
Target species:
  • Horse
  • Dog
Route of administration:
  • Intravenous use

Product details

Active substance and strength:
  • Levomethadone
    4.40
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intravenous use
    • Horse
      • Meat and offal
        3
        day
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN02AC52
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Slovenia
Package description:
  • Cardboard box with 1 clear glass (Type I) vial of 10 ml , 30 ml or 50 ml with a coated bromobutyl rubber stopper and aluminium cap.
  • Cardboard box with 1 clear glass (Type I) vial of 10 ml , 30 ml or 50 ml with a coated bromobutyl rubber stopper and aluminium cap.
  • Cardboard box with 1 clear glass (Type I) vial of 10 ml , 30 ml or 50 ml with a coated bromobutyl rubber stopper and aluminium cap.
  • Cardboard box with 1 clear glass (Type I) vial of 10 ml , 30 ml or 50 ml with a coated bromobutyl rubber stopper and aluminium cap. 5 ml (in a 10 ml sized vial)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application – change in strength (Article 19(1)(a) of Regulation (EU) 2019/6)
Marketing authorisation holder:
  • Alfasan Nederland B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Alfasan Nederland B.V.
Responsible authority:
  • Agency For Medicinal Products And Medical Devices Of The Republic Of Slovenia
Authorisation number:
  • DC/V/0781/002
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0384/001-002/DC
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 31/08/2023
Download
Slovenian (PDF)
Published on: 16/11/2023
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Slovenian (PDF)
Published on: 16/11/2023
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Slovenian (PDF)
Published on: 16/11/2023
Download

Package Leaflet and Labelling

English (PDF)
Published on: 31/08/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."